UnitedHealthcare says it’s dropping some of its Medicare Advantage plans that collectively cover 600,000 people.

In this week’s edition of InnovationRx, we look at a biotech entrepreneur treating a rare genetic disease, new tech aimed at ...

Novo Nordisk reported second quarter earnings a week after revising its 2025 outlook down on slower GLP-1 sales.

Trump demands U.S. drug prices match lowest international rates for some or face executive action. This article originally ...

Amgen stock dropped Wednesday despite a strong second quarter as investors look ahead to the next weight-loss readouts.

Cryotherapy, infant stem cells, extreme cold, IV infusions, red light therapy, blue light therapy … more Australians are ...

The majority of State Health Plan participants will become eligible in October for "an innovative no-cost surgical benefit" through a new partnership with a Dallas- based health care network.

In the second part of his Pharma Commerce video interview, Philip Sclafani, PwC's pharmaceutical and life sciences lead, ...

Weight loss medications such as Wegovy and Zepbound have garnered an enormous amount of attention recently for their ability to help some users lose significant amounts of weight relatively easily.

Detailed price information for Novo Nordisk A/S ADR (NVO-N) from The Globe and Mail including charting and trades.